Pharaoh Neuro has raised $20m to advance development and regulatory activities for its neurapheresis cerebrospinal fluid (CSF) management system, while simultaneously appointing a CEO and chief medical officer.
Pharaoh’s…
Pharaoh Neuro has raised $20m to advance development and regulatory activities for its neurapheresis cerebrospinal fluid (CSF) management system, while simultaneously appointing a CEO and chief medical officer.
Pharaoh’s…